Navigation Links
Microcoils help locate small lung nodules
Date:2/2/2009

OAK BROOK, Ill. - A new technique combining computed tomography (CT) with fiber-coated surgical microcoils allows physicians to successfully locate and remove small lung nodules without the need for a more invasive procedure, according to a new study published in the February issue of Radiology.

"Small lung nodules are much more difficult to successfully locate and remove than larger nodules," said the study's lead author, John Mayo, M.D., professor of radiology and cardiology at the University of British Columbia in Vancouver. "Using CT guidance, we can accurately place the microcoils at the precise location of the small nodules and guide video-assisted thoracoscopic surgery (VATS) removal."

A lung nodule is a relatively round lesion, or area of abnormal tissue located within the lung. Lung nodules do not typically cause pain or other symptoms and are most often detected by imaging exams. However, it is not always possible to tell from imaging tests whether a nodule is benign or cancerous.

"When a patient has a very small nodule identified, we can use the microcoil technique to definitively discover whether or not the nodule is malignant and remove the entire nodule in one procedure," Dr. Mayo said.

VATS is a minimally invasive technique in which one or more small incisions are made in the patient's chest and a small fiber optic camera and surgical instruments are inserted through the incisions. Images transmitted by the camera guide the physician through the procedure.

VATS can replace a traditional thoracotomy, a surgical procedure that uses one larger incision to gain access to the chest. VATS typically results in less pain and faster recovery time for the patient compared to open surgery.

Because small, peripheral lung nodules can be difficult to locate, physicians often have to resort to the more invasive thoracotomy procedure, removing larger amounts of lung tissue to successfully locate small nodules.

For the study, Dr. Mayo and colleagues used CT-guided microcoil placement to assist in VATS removal of 75 small, peripheral lung nodules in 69 patients ranging in age from 31 to 81 years. Four patients had two nodules treated, and two of the patients had second nodules removed at a later date. In all, 75 procedures were performed. The microcoil technique allowed the researchers to locate 100 percent of small nodules, and 97 percent of the lung nodules were successfully and completely removed with VATS.

The results show that with precise microcoil localization, even small nodules can be removed with VATS.

"The real beauty of this procedure is that we are able to remove the entire nodule and very little surrounding tissue, so there is no decrease in lung function," Dr. Mayo said. "Recovery time is significantly reduced in these patients as a result. Instead of the three- to six-week recovery period that follows a thoracotomy, these patients can return to work within two to three days."


'/>"/>

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
Source:Eurekalert

Related medicine news :

1. Service for Medical Transcription, World Wide Dictation, Relocates to New Ardsley, NY Headquarters
2. Law Offices of Christian Lodowski, Medical Malpractice Attorney, Relocates to New Office Park in Towson
3. New Website Helps Doctors and Dentists Locate Disability Insurance
4. Cantel Medical to Relocate Dutch Manufacturing Operations to the United States to Achieve Operating Savings
5. SNAPforSeniors Now Helps BenefitsCheckUp Users Locate Housing Options
6. Chesapeake to Expand and Relocate North American Pharmaceutical Packaging Operation
7. Gene markers located for hereditary prostate cancer
8. Former Johnson & Johnson Executive Gives Big Voice to Small Companies
9. Bioniche Named One of the Top 50 Best Small and Medium Employers in Canada
10. Frost & Sullivan Recognizes Neotropixs Approach to the Treatment of Small Cell Lung Cancer and Neuroendocrine Cancers
11. Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Aimed at ... human interest stories, which come courtesy of leaders in the nursing and health care ... from leading advocates and associations—namely Abilene Christian University. , As the nursing industry ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a ... (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the 90 ... their favorite way to cook a hot dog, far outpacing other cooking methods such ...
(Date:5/26/2016)... Atlanta, Georgia (PRWEB) , ... May 26, 2016 ... ... a certificate in intellectual property (IP) to its specialty academic programs. , Answering ... joins the college’s existing certificate programs in health law, and environmental and land ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: